Edwards Lifesciences (EW) Other Working Capital Changes (2009 - 2026)

Edwards Lifesciences' Other Working Capital Changes history runs 18 years deep, the most recent figure standing at $18.1 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 270.75% year-over-year to $18.1 million; the TTM figure through Mar 2026 stood at $52.4 million (up 945.16% YoY), while the FY2025 annual figure was $23.7 million, up 204.41% from the prior year.
• Other Working Capital Changes was $18.1 million for Q1 2026 at Edwards Lifesciences, up from $6.2 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $67.0 million in Q4 2023 to a low of -$39.8 million in Q4 2022.
• Historically, Other Working Capital Changes has averaged $5.9 million across 5 years, with a median of $1.5 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes soared 296.99% in 2022, then sank 966.67% in 2024.
• A 5-year view of Other Working Capital Changes shows it stood at -$39.8 million in 2022, then soared by 268.34% to $67.0 million in 2023, then slumped by 140.0% to -$26.8 million in 2024, then surged by 123.13% to $6.2 million in 2025, then jumped by 191.94% to $18.1 million in 2026.
• The last three Other Working Capital Changes figures came in at $18.1 million (Q1 2026), $6.2 million (Q4 2025), and $14.2 million (Q3 2025), per Business Quant data.